Conformation of ethyl (+)-(2S,3S)-3-{1-[N-(3-methylbutyl)amino]leucylcarbonyl}oxi-rane-2-carboxylate (loxistatin), a cysteine protease inhibitor: X-ray crystallographic and 1H nuclear magnetic resonance studies
- 1 January 1988
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of the Chemical Society, Perkin Transactions 2
- No. 6,p. 851-857
- https://doi.org/10.1039/p29880000851
Abstract
In order to establish the conformational characteristics of a cysteine protease inhibitor, the crystal and solution conformations of loxistatin have been determined by X-ray crystallographic and 1H n.m.r. spectroscopic analyses. The molecules were arranged in the crystal as a series of infinite parallel β-sheet structures formed via intermolecular N-H ⋯ O hydrogen bonds. The loxistatin molecule has a flattened, curved conformation, which appears to be energetically stable. Similar conformations of loxistatin were also observed in (CD3)2SO and CDCl3 solutions. On the basis of the results obtained, the relation between the conformation of loxistatin and its inhibitory activity was discussed and compared with the stereostructure of the papain–substrate analogue complex.Keywords
This publication has 0 references indexed in Scilit: